REPLIGEN CORP (RGEN)
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
25 May 2022
DAWES KAREN A
Director
REPLIGEN CORP
(RGEN)
88,671-14%
14,715
$150.51
$2,214,819.20
SELL
10 Nov 2021
DAWES KAREN A
Director
REPLIGEN CORP
(RGEN)
95,568-4%
4,783
$263.93
$1,262,354.80
SELL
17 Aug 2021
DAWES KAREN A
Director
REPLIGEN CORP
(RGEN)
95,061-16%
18,876
$254.18
$4,797,235.00
BUY
13 Jul 2021
DAWES KAREN A
Director
REPLIGEN CORP
(RGEN)
117,462+1%
1,520
$202.23
$307,389.60
SELL
18 Jun 2020
DAWES KAREN A
Director
REPLIGEN CORP
(RGEN)
116,762-13%
18,705
$115.20
$2,154,850.80
SELL
20 Apr 2020
DAWES KAREN A
Director
REPLIGEN CORP
(RGEN)
118,032-9%
12,200
$104.57
$1,275,717.10
SELL
18 Mar 2020
Cox John
Director
REPLIGEN CORP
(RGEN)
4,984-84%
26,736
$95.27
$2,547,035.20
SELL
4 Mar 2020
Cox John
Director
REPLIGEN CORP
(RGEN)
2,781-78%
10,000
$93.39
$933,900.00
SELL
24 Feb 2020
Cox John
Director
REPLIGEN CORP
(RGEN)
7,136-38%
4,455
$92.81
$413,454.80
SELL
9 Aug 2018
EDDLEMAN ROY T
10% Owner
REPLIGEN CORP
(RGEN)
720,000-13%
116,073
$49.63
$5,760,536.00
SELL
6 Aug 2018
EDDLEMAN ROY T
10% Owner
REPLIGEN CORP
(RGEN)
409,215-11%
53,927
$49.05
$2,645,146.50
SELL
16 May 2018
EDDLEMAN ROY T
10% Owner
REPLIGEN CORP
(RGEN)
2,925,976-3%
118,850
$42.07
$5,000,019.50
SELL
8 May 2018
EDDLEMAN ROY T
10% Owner
REPLIGEN CORP
(RGEN)
410,000-22%
120,000
$40.62
$4,874,457.00
Home